IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000071 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
88,147
Total Value
$703,138.18
P&L
+inf% (+$2,518,370.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Clinical Develop Ofcr | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 21,685 | $0.00 | $0.00 | 73,192 | Direct | โ | View Details | |
EVP, Chf Clinical Develop Ofcr | Common Stock | โ | Jan 16, 2026 | Sale | 9,302 | $75.59 | $703,138.18 | 63,890 | Direct | โ | View Details | |
EVP, Chf Clinical Develop Ofcr | Performance Restricted Stock Units | Derivative | Jan 15, 2026 | Grant/Award | 25,800 | $0.00 | $0.00 | 91,237 | Direct | โ | View Details | |
EVP, Chf Clinical Develop Ofcr | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 21,685 | $0.00 | $0.00 | 39,251 | Direct | โ | View Details | |
EVP, Chf Clinical Develop Ofcr | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 9,675 | $0.00 | $0.00 | 48,926 | Direct | โ | View Details |